文献速递性腺与生殖内分泌糖尿病

多囊卵巢综合征女孩循环miR-451a水平降低:随机治疗的不同效果

Low Circulating Levels of miR-451a in Girls with Polycystic Ovary Syndrome: Different Effects of Randomized Treatments.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

研究评估了多囊卵巢综合征(PCOS)女孩的基线microRNA谱,以及口服避孕药(OC)或螺内酯-吡格列酮-二甲双胍(SPIOMET)治疗1年的效果。PCOS女孩循环miR-451a等显著降低,SPIOMET(而非OC)使miRNA谱正常化,且miR-451a与治疗后排卵率相关。

要点

  • PCOS女孩循环miR-451a、miR-652-3p、miR-106b-5p和miR-206显著降低。
  • SPIOMET治疗1年使miRNA谱正常化,OC治疗无此效果。
  • miR-451a与治疗后排卵率密切相关(r=0.66;P<.0001)。

核心结论

  • SPIOMET治疗1年使PCOS女孩的miRNA谱正常化。
  • 循环miR-451a可能成为指导青春期PCOS诊断和治疗的生物标志物。

研究设计与样本

  • 随机、开放标签、单中心预试验,PCOS女孩n=31,年龄15.7岁,BMI 23.1 kg/m2。
  • 健康年龄和BMI匹配的对照女孩n=13。
  • 通过RNA测序评估miRNA谱,RT-qPCR在全部研究人群中验证差异表达的miRNA。

主要发现

  • 与对照组相比,PCOS女孩循环miR-451a、miR-652-3p、miR-106b-5p和miR-206浓度显著降低。
  • 通路富集分析显示这些miRNA靶向能量稳态和细胞周期调控相关基因。
  • 本研究中miR-451a诊断PCOS的敏感性和特异性均为100%。
  • SPIOMET(而非OC)伴随治疗中miRNA谱正常化。
  • OC或SPIOMET治疗1年后的miR-451a浓度与治疗后排卵率密切相关(r=0.66;P<.0001)。

临床怎么用

  • 循环miR-451a可能作为青春期PCOS诊断和治疗的生物标志物。
  • SPIOMET治疗可能通过正常化miRNA谱改善PCOS女孩的排卵结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Polycystic ovary syndrome (PCOS) is a prevalent disorder in adolescent girls, purportedly driven by hepato-visceral fat excess, and often followed by subfertility and type 2 diabetes. OBJECTIVE: We studied the baseline microRNA (miRNA) profile of girls with PCOS, and the effects of a randomized treatment with an oral contraceptive (OC) or with spironolactone-pioglitazone-metformin (SPIOMET, aiming at loss of hepato-visceral fat excess) for 1 year. DESIGN & PATIENTS: The miRNA profile was assessed by RNA sequencing in girls with PCOS who had participated in a randomized, open-label, single-center, pilot study (n = 31; age 15.7 years, body mass index (BMI) 23.1 kg/m2). Healthy age- and BMI-matched girls (n = 13) served as controls. Differentially expressed miRNAs were validated by RT-qPCR in the entire study population. Post-treatment ovulation rates were assessed by salivary progesterone in PCOS girls. SETTING: Endocrinology Department, University Hospital. RESULTS: Girls with PCOS, compared with controls, had markedly reduced concentrations of circulating miR-451a, miR-652-3p, miR-106b-5p, and miR-206; pathway enrichment analysis showed that these miRNAs target genes involved in energy homeostasis and cell cycle control. In the present study, miR-451a could diagnose PCOS with 100% sensitivity and 100% specificity. SPIOMET (but not OC) was accompanied by on-treatment normalization of the miRNA profile in girls with PCOS; miR-451a concentrations after 1 year on OC or SPIOMET treatment associated closely (r = 0.66; P < .0001) with post-treatment ovulation rates. CONCLUSION: SPIOMET treatment for 1 year normalizes the miRNA profile of girls with PCOS. Circulating miR-451a may become a biomarker to guide the diagnosis and treatment of PCOS in adolescence.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Díaz M, Bassols J, López-Bermejo A, et al. Low Circulating Levels of miR-451a in Girls with Polycystic Ovary Syndrome: Different Effects of Randomized Treatments. J Clin Endocrinol Metab. 2020. PMID: 31730174. doi:10.1210/clinem/dgz204

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。